CHANGE OF RECEIPT DATE FOR EARLY CLINICAL TRIALS OF NEW ANTI-CANCER AGENTS WITH 
PHASE I EMPHASIS

Release Date:  January 14, 2002

NOTICE:  NOT-CA-02-015

National Cancer Institute

The National Cancer Institute (NCI) wishes to give notice of a change of 
receipt date for applications submitted in response to RFA CA-02-011, EARLY 
CLINICAL TRIALS OF NEW ANTI-CANCER AGENTS WITH PHASE I EMPHASIS.  This RFA 
appeared in the November 19, 2001 issue of the NIH Guide for Grants and 
Contracts.  The previous receipt date of March 21, 2002 has been changed to 
March 28, 2002.

All other aspects of this RFA remain unchanged.  This RFA can be accessed at 
the following URL:  
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-02-011.html.
                         
INQUIRIES

Inquiries regarding this notice may be directed to:

Dr. Louise B. Grochow
Chief, Investigational Drug Branch 
Cancer Therapy Evaluation Program 
Division of Cancer Treatment and Diagnosis
National Cancer Institute 
Executive Plaza North, Room 7131
6130 Executive Blvd MSC 7426
Bethesda, MD  20892-7432 
Telephone:  (301) 496-1196 
Fax:  (301) 402-0428
E-mail:  grochowl@ctep.nci.nih.gov


Return to Volume Index

Return to NIH Guide Main Index


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.